23.Hibbard,
J.S. 3.15% Chlorascrub New Drug Application (NDA). Project consultant
for drug development in the U.S. Reviewed and commented on protocols for
two pivotal clinical studies. Consulted on both studies from pre-study
site visits to closing site visits. Reviewed and commented on the
Clinical Statistical Reports. Wrote and prepared sections 7, 8, 9, 10,
11, and 12 and reviewed and commented on sections 2, 3, 5 and 6 of the
NDA. The NDA was filed in 2004 and approved by the FDA in 2005.
24.John S.
Hibbard. Comparative Analysis of the Antimicrobial Activity and Safety
of Current Antiseptic Agents. An Oral Presentation at the Infusion
Nurses Society, National Academy of Infusion Therapy meeting, Session
Code 001, May 1, 2004, Salt Lake City, Utah.
25.John S.
Hibbard. Analyses Comparing the Antimicrobial Activity and Safety of
Current Antiseptic Agents: A Review. Journal of Infusion Nursing,
May-June, 28 No.3: 194-207, 2005
